Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) Short Interest Down 74.5% in January

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) saw a large drop in short interest in January. As of January 30th, there was short interest totaling 4,007 shares, a drop of 74.5% from the January 15th total of 15,707 shares. Based on an average daily trading volume, of 16,755 shares, the days-to-cover ratio is currently 0.2 days. Based on an average daily trading volume, of 16,755 shares, the days-to-cover ratio is currently 0.2 days.

Coeptis Therapeutics Stock Performance

Shares of Coeptis Therapeutics stock traded down $0.00 on Thursday, hitting $0.01. 3,912 shares of the company traded hands, compared to its average volume of 20,519. The stock’s 50 day moving average price is $0.01 and its 200-day moving average price is $0.02. Coeptis Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.05.

Coeptis Therapeutics Company Profile

Coeptis Therapeutics is a clinical‐stage biopharmaceutical company focused on developing novel therapies for neurodegenerative and neuroinflammatory disorders. The company’s proprietary platform is based on engineered analogs of small heat shock proteins designed to modulate cellular stress responses, reduce inflammation and protect neurons from degeneration. Coeptis’s lead program is being advanced in amyotrophic lateral sclerosis (ALS), with additional preclinical studies underway in conditions such as multiple sclerosis and other central nervous system diseases.

Using its heat shock protein analog technology, Coeptis seeks to address the underlying pathology of neurodegeneration rather than merely managing symptoms.